Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mari Takaai is active.

Publication


Featured researches published by Mari Takaai.


European Journal of Pharmacology | 2008

Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells.

Mari Takaai; Hiroki Morishita; Kazuya Ishida; Masato Taguchi; Yukiya Hashimoto

The aim of the present study was to characterize the intestinal absorption of ribavirin (1-beta-d-ribofuranosyl-1, 2, 4-trizole-3-carboxamide). We evaluated the contribution of Na(+)-dependent and -independent transport to ribavirin absorption in the rat intestine using an in situ closed loop method. In addition, we performed pharmacokinetic analysis of the uptake of ribavirin in human intestinal epithelial LS180 cells, and also evaluated the effect of extracellular Na(+) concentration and an inhibitor of the Na(+)-independent equilibrative nucleoside transporter, nitrobenzylmercaptopurine ribonucleoside (NBMPR), on the uptake of ribavirin in the cells. In the presence and also absence of Na(+) in rat intestinal loops, more than 80% of the administered dose (50 microg at a concentration of 100 microg/ml=409 microM) of ribavirin was absorbed in 40 min. The absorption of ribavirin in the rat intestine was significantly reduced by coadministration of 10 mg/ml (=37.3 mM) inosine. In LS180 cells, 100 microM ribavirin was taken up time-dependently, and the influx clearance of the drug was similar to the efflux clearance. Five mM inosine and mizoribine reduced the uptake of 100 microM ribavirin in LS180 cells. The absence of extracellular Na(+) decreased the uptake of 100 microM ribavirin only weakly in the cells, whereas the uptake of 100 microM-2 mM ribavirin was markedly decreased by 100 microM NBMPR. These findings suggested that Na(+)-independent nucleoside transport contributes significantly to intestinal absorption of ribavirin at relatively high concentrations (>or=100 microM).


Biological & Pharmaceutical Bulletin | 2006

Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells.

Kazuya Ishida; Mari Takaai; Yukiya Hashimoto


Biological & Pharmaceutical Bulletin | 2007

Pharmacokinetic Analysis of Transcellular Transport of Levofloxacin across LLC-PK1 and Caco-2 Cell Monolayers

Mari Takaai; Hisaki Suzuki; Kazuya Ishida; Katsutoshi Tahara; Yukiya Hashimoto


Biological & Pharmaceutical Bulletin | 2010

Membrane Transport Mechanisms of Quinidine and Procainamide in Renal LLC-PK1 and Intestinal LS180 Cells

Miki Masago; Mari Takaai; Jumpei Sakata; Asuka Horie; Toshikazu Ito; Kazuya Ishida; Masato Taguchi; Yukiya Hashimoto


Biological & Pharmaceutical Bulletin | 2009

Membrane transport mechanisms of mizoribine in the rat intestine and human epithelial LS180 cells.

Kazuya Ishida; Mari Takaai; Ayano Yotsutani; Masato Taguchi; Yukiya Hashimoto


Drug Metabolism and Pharmacokinetics | 2008

Directional Transcellular Transport of Bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 Cells, but not in Renal Epithelial LLC-PK1 Cells

Katsutoshi Tahara; Yuka Kagawa; Mari Takaai; Masato Taguchi; Yukiya Hashimoto


Biological & Pharmaceutical Bulletin | 2007

Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Aripiprazole in Healthy Japanese Males

Toshiko Koue; Masanori Kubo; Tomoo Funaki; Tsuyoshi Fukuda; Junichi Azuma; Mari Takaai; Yuichiro Kayano; Yukiya Hashimoto


Drug Metabolism and Pharmacokinetics | 2008

The Apical Uptake Transporter of Levofloxacin is Distinct from the Peptide Transporter in Human Intestinal Epithelial Caco-2 Cells

Shiro Fukumori; Toshiya Murata; Mari Takaai; Katsutoshi Tahara; Masato Taguchi; Yukiya Hashimoto


Drug Metabolism and Pharmacokinetics | 2011

Evaluation of Limited Sampling Designs to Estimate Maximal Concentration and Area under the Curve of Mizoribine in Pediatric Patients with Renal Disease

Kazuya Ishida; Hisashi Kaneda; Osamu Uemura; Katsumi Ushijima; Kazuhide Ohta; Yoshimitsu Goto; Kenichi Satomura; Masaki Shimizu; Mikiya Fujieda; Masashi Morooka; Takuji Yamada; Masayoshi Yamada; Naohiro Wada; Mari Takaai; Yukiya Hashimoto


Drug Metabolism and Pharmacokinetics | 2008

Additional Notes on Clinical Repeated-Dose Pharmacokinetic Trials Applying a Peak-and-Trough Sampling Design to Estimate Oral Clearance

Mari Takaai; Yuichiro Kayano; Takako Shimizu; Masato Taguchi; Yukiya Hashimoto

Collaboration


Dive into the Mari Takaai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenichi Satomura

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge